Cargando…
In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
Engineering chimeric antigen receptors (CAR) or T cell receptors (TCR) helps create disease-specific T cells for targeted therapy, but the cost and rigor associated with manufacturing engineered T cells ex vivo can be prohibitive, so programing T cells in vivo may be a viable alternative. Here we re...
Autores principales: | Parayath, N. N., Stephan, S. B., Koehne, A. L., Nelson, P. S., Stephan, M. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695830/ https://www.ncbi.nlm.nih.gov/pubmed/33247092 http://dx.doi.org/10.1038/s41467-020-19486-2 |
Ejemplares similares
-
Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
por: Zhang, F., et al.
Publicado: (2019) -
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
por: Kang, Diana D., et al.
Publicado: (2023) -
In Vitro-Transcribed mRNA Chimeric Antigen Receptor T Cell (IVT mRNA CAR T) Therapy in Hematologic and Solid Tumor Management: A Preclinical Update
por: Soundara Rajan, Thangavelu, et al.
Publicado: (2020) -
Ribozyme Assays to Quantify the Capping Efficiency of In Vitro-Transcribed mRNA
por: Vlatkovic, Irena, et al.
Publicado: (2022) -
Genetic in situ engineering of myeloid regulatory cells controls inflammation in autoimmunity
por: Parayath, N.N., et al.
Publicado: (2021)